Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5665734 | 0.81 | TSHR (0.46) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL9352413 | 0.80 | TSHR (0.42) | TSHRHPGDALDH1A1TP53HIF1A | |
| Potassium Ion SCHEMBL31756936 | 0.80 | TSHR (0.42) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL2184214 | 0.79 | TSHR (0.45) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL27794908 | 0.79 | TSHR (0.45) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL37396 | 0.79 | TSHR (0.45) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL10024379 | 0.79 | TSHR (0.45) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL16520914 | 0.79 | TSHR (0.45) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL6368708 | 0.79 | TSHR (0.45) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL183980 | 0.77 | TSHR (0.43) | TSHRHPGDALDH1A1TP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11279731-B2 | Ligand functional substrates | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-03-22 | — | — | US | disclosed |
| US-11111320-B2 | Addition-fragmentation oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-09-07 | — | — | US | disclosed |
| EP-3326711-B1 | GRAFT COPOLYMER FUNCTIONALIZED ARTICLE | 3M INNOVATIVE PROPERTIES CO (US) | 2021-07-07 | — | — | EP | disclosed |
| CN-107406723-B | Addition-fragmentation oligomers | 3M创新有限公司 | 2021-05-07 | — | — | CN | disclosed |
| EP-2675783-B1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-04-22 | — | — | EP | disclosed |
| EP-3259323-B1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-02-26 | — | — | EP | disclosed |
| US-20200031961-A1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-01-30 | — | — | US | disclosed |
| US-10479848-B2 | Addition-fragmentation oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-11-19 | — | — | US | disclosed |
| US-10471398-B2 | Graft copolymer functionalized article | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-11-12 | — | — | US | disclosed |
| US-10370322-B2 | Addition-fragmentation agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-08-06 | — | — | US | disclosed |
| US-20020132927-A1 | Pressure sensitive adhesives possessing high load bearing capability | 3M INNOVATIVE PROPERTIES COMPANY | 2002-09-19 | — | — | US | disclosed |
| US-6448337-B1 | CURABLE SYRUP COMPRISING DUAL POLYMERS CONTAINING PENDANT INTERREACTIVE GROUPS, FREE RADICAL POLYMERIZABLE SOLVENT MONOMER AND PHOTOINITIATOR; BALANCED ADHESIVE AND COHESIVE CHARACTERISTICS | 3M INNOVATIVE PROPERTIES COMPANY | 2002-09-10 | — | — | US | disclosed |
| EP-1230315-A1 | PRESSURE SENSITIVE ADHESIVES POSSESSING HIGH LOAD BEARING CAPABILITY | 3M Innovative Properties Company (US) | 2002-08-14 | — | — | EP | disclosed |
| WO-2002038694-A1 | PRESSURE SENSITIVE ADHESIVES POSSESSING HIGH LOAD BEARING CAPABILITY | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2002-05-16 | — | — | WO | disclosed |
| EP-0808348-B1 | CROSS-LINKABLE PRESSURE SENSITIVE ADHESIVE AND PROCESS FOR THE PRODUCTION OF AN ARTICLE COATED WITH A CROSSLINKED PRESSURE SENSITIVE ADHESIVE | MINNESOTA MINING & MFG (US) | 1999-05-06 | — | — | EP | disclosed |
| US-5741543-A | CONTAINING UNSATURATED MONOMERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-04-21 | — | — | US | disclosed |
| EP-0808348-A1 | PROCESS FOR THE PRODUCTION OF AN ARTICLE COATED WITH A CROSSLINKED PRESSURE SENSITIVE ADHESIVE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-11-26 | — | — | EP | disclosed |
| WO-1996024644-A1 | PROCESS FOR THE PRODUCTION OF AN ARTICLE COATED WITH A CROSSLINKED PRESSURE SENSITIVE ADHESIVE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-08-15 | — | — | WO | disclosed |
| US-4378411-A | HAVING ETHLENICALLY UNSATURATED PEPTIDE GROUPS; FOR GRAPHIC ARTS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1983-03-29 | — | — | US | disclosed |
| US-4304705-A | Radiation-curable polymers containing pendant unsaturated peptide groups derived from azlactone polymers | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1981-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10479848-B2 | Addition-fragmentation oligomers | ECPAS, ITGA8, NBAS | TSHR 4794/4885HPGD 3653/4885ALDH1A1 2212/4885 |
| US-10370322-B2 | Addition-fragmentation agents | NR4A1, PARP14, MTX1 | TSHR 1778/4885HPGD 3857/4885ALDH1A1 3630/4885 |
| US-20200031961-A1 | ADDITION-FRAGMENTATION OLIGOMERS | ECPAS, ITGA8, NBAS | TSHR 4794/4885HPGD 3653/4885ALDH1A1 2212/4885 |
| US-11279731-B2 | Ligand functional substrates | PCNA, POLM, POLL | TSHR 4365/4885HPGD 3788/4885ALDH1A1 4565/4885 |
| US-11111320-B2 | Addition-fragmentation oligomers | ECPAS, ITGA8, NBAS | TSHR 4794/4885HPGD 3653/4885ALDH1A1 2212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.